Arrowhead Pharmaceuticals (ARWR) Treasury Shares (2012 - 2026)

Arrowhead Pharmaceuticals' Treasury Shares history runs 14 years deep, the most recent figure standing at $5.9 million for Q1 2025.

• Quarterly Treasury Shares changed N/A year-over-year to $5.9 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $5.9 million (changed N/A YoY) and the FY2024 annual result came in at $4.9 million, up 15.84% from the prior year.
• Treasury Shares was $53.2 million for Q1 2026 at Arrowhead Pharmaceuticals, roughly flat from $53.2 million in the prior quarter.
• Across five years, Treasury Shares topped out at $5.9 million in Q1 2025 and bottomed at $1.7 million in Q2 2023.
• A 5-year average of $3.6 million and a median of $3.8 million in 2021 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2023 — Treasury Shares tumbled 62.23% — and 2024, when it surged 66.24%.
• Arrowhead Pharmaceuticals' Treasury Shares stood at $53.2 million in 2025, then changed by 0.0% to $53.2 million in 2026.
• Business Quant data shows ARWR's Treasury Shares at $53.2 million in Q1 2026, $53.2 million in Q4 2025, and $53.2 million in Q3 2025.